Form D · Biotechnology

Applied BioCode, Inc.

Santa Fe Springs, CA · CIK 0001553480

Offering snapshot reported Apr 8, 2016 · SEC filing

Reported sold
$9.26M
Offering amount: $12M
Investors reported
13
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 15, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 8, 2016Initial$9,255,600No comparison13SEC filing
Dec 5, 2012Initial$7,000,080No comparison12SEC filing
Dec 5, 2012Initial$1,237,487No comparison14SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-260891

Source: Form D, filed Apr 8, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Zonh Zen "Winston" Ho Director, Executive
R. April Ho Executive
George J. Lee Director
Dean Tsao Director
Edward Yang Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
10020 Pioneer Blvd. Suite 102
Santa Fe Springs, CA, 90670